Infections and Psoriasis Treatment: More “Real-World” Data Needed with Critical Appraisal Luigi Naldi Journal of Investigative Dermatology Volume 137, Issue 2, Pages 271-274 (February 2017) DOI: 10.1016/j.jid.2016.10.022 Copyright © 2016 The Author Terms and Conditions
Figure 1 Selected factors affecting risk assessment of infection with exposure to drugs in a registry-based cohort study. A summary representation of variables influencing risk evaluation being connected with different time points in a study: entry, follow-up and outcome. Journal of Investigative Dermatology 2017 137, 271-274DOI: (10.1016/j.jid.2016.10.022) Copyright © 2016 The Author Terms and Conditions